Clinical trials
Terminated Myelodysplastic Syndromes trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| AbbVie | 1 |
| Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
| Hemavant Sciences GmbH | 1 |
| Janssen Research & Development, LLC | 1 |
| Kiadis Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 22 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Leukemia | 2 |
| Anemia | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Lymphatic Diseases | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.